Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Uterine Cervical Neoplasms × Brachytherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

pembrolizumab 3 tisotumab vedotin 2 Cisplatin 2 sacituzumab govitecan 1 Vinorelbine 1 Topotecan 1 Saline Solution 1 Pemetrexed 1 Paclitaxel 1 Irinotecan 1 Gemcitabine 1 Carboplatin 1 Brachytherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04221945 2026-02-20

KEYNOTE-A18

Merck Sharp & Dohme LLC

Phase 3 Completed

1,060 enrolled 30 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡